Article
A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes.
Journal of endocrinological investigation - 1 Oct 2015
de Farias C R, Cardoso B R, de Oliveira G M B, de Mello Guazzelli I C, Catarino R M, Chammas M C, Cozzolino S M F, Knobel M
Abstract excerpt
PURPOSE: To analyze the impact of selenium supplementation on serum antiTPO levels and thyroid echogenicity in patients with CAT, evaluating the response in subgroups with different GPx1 genotypes. METHODS: CAT patients (n = 55) with positive antiTPO were randomized to selenomethionine (SeMet) 20...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
